vimarsana.com
  1. Home
  2. Live Updates
  3. Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint : vimarsana.com

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Ireland ,Erin Linnihan ,Elizabethhz Thompson ,Geoff Curtis ,Tina Ventura ,Facebook ,Twitter ,Linkedin ,British Isles Lupus Assessment Group ,Nasdaq ,Exchange Commission ,Corporate Affairs ,Instagram ,Combined Lupus Assessment ,Daxdilimab Phase ,Systemic Lupus ,Systemic Lupus Erythematosus Responder Index ,Looking Statements ,United States Securities ,Vice President ,Chief Investor Relations Officer ,Investor Relations ,Chief Communications Officer ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.